SMITH+NEPHEW ADR5 DL-20/2 revenue breakdown overview

SMITH+NEPHEW ADR5 DL-20/2 revenue for the last year amounted to 5.03 B EUR, the most of which — 2.01 B EUR — came from its highest performing source at the moment, Orthopaedics, the year earlier bringing 1.97 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought SMITH+NEPHEW ADR5 DL-20/2 2.70 B EUR, and the year before that — 2.58 B EUR.